2005
DOI: 10.1038/sj.onc.1209185
|View full text |Cite
|
Sign up to set email alerts
|

p53 promotes adenoviral replication and increases late viral gene expression

Abstract: The tumor suppressor protein, p53, plays a critical role in viro-oncology. However, the role of p53 in adenoviral replication is still poorly understood. In this paper, we have explored further the effect of p53 on adenoviral replicative lysis. Using well-characterized cells expressing a functional p53 (A549, K1neo, RKO) and isogenic derivatives that do not (K1scx, RKOp53.13), we show that virus replication, late virus protein expression and both wtAd5 and ONYX-015 virus-induced cell death are impaired in cell… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
38
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(38 citation statements)
references
References 48 publications
0
38
0
Order By: Relevance
“…Although SIFT results showed all mutations apart from R273H were deleterious, the R273H mutation has been reported to have defective activity toward promoters of various genes, including BAX, MDM2, and WAF1 (15). We have also found that the R273H mutation fails to enhance activity of adenoviral major late promoter, the principal promoter regulating expression of late virus protein in the presence of E1A (16). The average age of patients with mutant TP53 was significantly younger at diagnosis than those with wild-type (WT) TP53 (49.1 F 3.5 and 59.4 F 1.4 years, respectively; P = 0.0102), which agrees with Louis et al (17).…”
Section: Resultsmentioning
confidence: 95%
“…Although SIFT results showed all mutations apart from R273H were deleterious, the R273H mutation has been reported to have defective activity toward promoters of various genes, including BAX, MDM2, and WAF1 (15). We have also found that the R273H mutation fails to enhance activity of adenoviral major late promoter, the principal promoter regulating expression of late virus protein in the presence of E1A (16). The average age of patients with mutant TP53 was significantly younger at diagnosis than those with wild-type (WT) TP53 (49.1 F 3.5 and 59.4 F 1.4 years, respectively; P = 0.0102), which agrees with Louis et al (17).…”
Section: Resultsmentioning
confidence: 95%
“…Cells were also transfected with either pCMV5.PAX8, pCMVPAX2b, pCMVPAX2c, or control pcDNA3 plasmids. Preparation of cell lysates and measurement of luciferase activity (Promega) have been previously described (26). Assays were performed in duplicate and repeated at least twice.…”
Section: Methodsmentioning
confidence: 99%
“…20,21,23 Studies by Braithwaite and coworkers have also proposed the hypothesis that p53 is actually needed by Ad to exert a cytopathic effect. 24,25 Another ambiguous point concerning ONYX-015 biology relates to the original idea linking the activation of the G 1 /S checkpoint to the abortion of the viral cycle in wt cells. As a matter of fact, the G 1 /S checkpoint is linked to the activity of pRb, 26,27 which is expected to be inactivated by E1A also in ONYX-015-infected cells.…”
Section: Introductionmentioning
confidence: 99%